Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.
about
Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@ast
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@en
type
label
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@ast
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@en
prefLabel
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@ast
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@en
P2093
P2860
P1476
Monitoring of cyclooxygenase-2 ...... ents with lung adenocarcinoma.
@en
P2093
P2860
P304
P577
2015-05-01T00:00:00Z